Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau.

Archives of neurology

Volumn 69, Issue 6, 2012, Pages 709-713

  Desikan, Rahul S ^a   McEvoy, Linda K ^b   Thompson, Wesley K ^b   Holland, Dominic ^b   Brewer, James B ^b   Aisen, Paul S ^b   Sperling, Reisa A ^b   Dale, Anders M ^b   Alzheimer's Disease Neuroimaging Initiative, ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CANADA; CEREBROSPINAL FLUID; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; MALE; PSYCHOLOGICAL RATING SCALE; STATISTICAL MODEL; UNITED STATES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CANADA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LINEAR MODELS; MALE; PEPTIDE FRAGMENTS; PSYCHIATRIC STATUS RATING SCALES; TAU PROTEINS; UNITED STATES;

EID: 84862882173     PISSN: None     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.3354     Document Type: Article

References (0)